American Century Investments is a pure play asset manager serving the best interests of clients worldwide for more than 60 years. As of 31 December 2022, the firm managed USD200bn in AUM across a broad range of global investment solutions, including ESG capabilities.
ACI has been present in Europe since 2008, with the opening of a London office, expanded in 2019 with a Frankfurt office.
The decision to invest with American Century also enables our clients to make a meaningful impact by funding research aiming to cure diseases such as Alzheimer’s, diabetes and cancer. Through its distinct ownership model, American Century directs over 40% of dividends to its owner, the Stowers Institute for Medical Research, a world-class biomedical research organization.
Since 2000, the firm has distributed 1.9bn USD in dividends to the Institute to fund fundamental medical research.
Our UCITS fund range are across global growth equity, emerging markets, and impact investing, all of which contain a comprehensive ESG integration framework within the investment process and are SFDR classified 6-9.
